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AbsTrACT
Tremor is the most common movement disorder 
worldwide, but diagnosis is challenging. in 2018, the 
task force on tremor of the international Parkinson 
and Movement Disorder Society published a consensus 
statement that proposes a tremor classification along 
two independent axes: a clinical tremor syndrome and 
its underlying aetiology. in line with this statement, we 
here propose a stepwise diagnostic approach that leads 
to the correct clinical and aetiological classification of 
upper limb tremor. we also describe the typical clinical 
signs of each clinical tremor syndrome. A key feature 
of our algorithm is the distinction between isolated 
and combined tremor syndromes, in which tremor is 
accompanied by bradykinesia, cerebellar signs, dystonia, 
peripheral neuropathy or brainstem signs. This distinction 
subsequently informs the selection of appropriate 
diagnostic tests, such as neurophysiology, laboratory 
testing, structural and dopaminergic imaging and genetic 
testing. we highlight treatable metabolic causes of 
tremor, as well as drugs and toxins that can provoke 
tremor. The stepwise approach facilitates appropriate 
diagnostic testing and avoids unnecessary investigations. 
we expect that the approach offered in this article will 
reduce diagnostic uncertainty and increase the diagnostic 
yield in patients with tremor.
InTroduCTIon
Although tremor is the most common movement 
disorder and therefore frequently encountered by 
neurologists,1 diagnosing tremor accurately can be 
challenging. The clinical presentation of a patient 
with tremor can range from a relatively isolated 
symptom to a complex syndrome, incorporating 
multiple signs and symptoms. In 2018, the task 
force on tremor of the International Parkinson and 
Movement Disorder Society published a consensus 
statement in which a tremor classification along 
two independent axes is proposed2: determination 
of a clinical syndrome based on clinical features 
(axis 1), and determination of an aetiology (axis 
2). For example, a bilateral upper limb action 
tremor without other neurological signs is classi-
fied as essential tremor (ET) on axis 1. The same 
patient may have a mutation in a gene that often 
causes dystonia; this is classified as the aetiology on 
axis 2. However, the axis 1 diagnosis of ET is not 
changed until dystonia develops (if it ever does).3 In 
the current paper, we propose a practical approach 
in line with the consensus statement, to aid prac-
tising clinicians in diagnosing patients with tremor. 
While this approach has not been tested yet, it is 
based on the current literature and in line with the 
steps taken at our Expertise Centres for Move-
ment Disorders. The first three steps we propose 
will lead to identification of a clinical syndrome, 
corresponding to axis 1. The subsequent steps will 
help in establishing an aetiology where possible 
(axis 2). Because of its prevalence and diagnostic 
complexity, we will focus on visible upper limb 
tremor, and omit discussion of related movement 
disorders such as palatal tremor and orthostatic 
tremor. Our aims are to provide organising princi-
ples on how to interpret clinical symptoms, and to 
provide guidelines for diagnostic testing, in which 
we recommend what is indicated while steering 
clear from unnecessary investigations. We acknowl-
edge that many of these recommendations are based 
on expert opinion. This reflects the current state of 
the field, given that many clinical tremor syndromes 
lack a gold standard against which clinical signs or 
ancillary investigations can be tested. A systematic 
approach to phenotype patients with upper limb 
tremor will, however, make it easier to test and 
validate new biomarkers in future research. Our 
stepwise approach to tremor diagnosis is presented 
in figure 1.
step 1: is the movement disorder really tremor?
The first step in diagnosing tremor is the identifi-
cation of hyperkinetic movements as ‘tremulous’. 
Tremor is defined as an involuntary, rhythmic, 
oscillatory movement of a body part.2 The most 
important alternative diagnosis is myoclonus, 
especially high frequency cortical myoclonus (e in 
familial cortical myoclonus), polyminimyoclonus 
(eg, in multiple system atrophy), peripheral myoc-
lonus (which sometimes occurs in inflammatory 
neuropathies or radiculopathies) or asterixis (a nega-
tive myoclonus that looks like a flapping tremor of 
the hands when the wrists are extended).4 5 More-
over, the rhythmic, low- frequency jerks in ongoing 
focal epilepsy (epilepsia partialis continua) can 
be misinterpreted as unilateral jerky rest tremor.4 
Generally, a ‘jerky’ aspect ought to raise suspicion 
of myoclonus as the movement disorder in ques-
tion, rather than tremor. However, the distinction 
between high frequency myoclonus and tremor on 
the basis of ‘rhythmicity’ is complicated by the fact 
that tremor is almost never perfectly rhythmic. In 
fact, a jerky or irregular aspect is part of the char-
acteristic phenotype of some tremor syndromes, 
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Figure 1 eight- step diagnostic approach to upper limb tremor. DT, 
dystonic tremor; ePT, enhanced physiological tremor; eT, essential tremor.
in doubt, polymyography can be used to differentiate between 
myoclonus and tremor: polymyography is further described in 
step 3. Naturally, tremor and myoclonus are not mutually exclu-
sive: patients can have both movement disorders.
step 2: characterise the tremor clinically
The neurological examination is the key tool to establish a clin-
ical tremor syndrome, that is, an axis 1 classification. This is 
of crucial importance, as the tremor syndrome is used in later 
steps to guide our choices for diagnostic tests to elucidate the 
underlying aetiology (ie, an axis 2 classification). In figure 2, we 
propose a practical clinical algorithm that helps to accurately 
diagnose a tremor syndrome. Before entering this algorithm, it 
is useful to characterise the tremor using the features outlined 
in box 1. The algorithm contains decision points in an order 
that facilitates ‘short- cuts’ to the diagnosis of a clinical tremor 
syndrome.
First, it is useful to look for signs of a functional movement 
disorder. Tremor is a common phenotype of functional move-
ment disorders.7 Signs to investigate are entrainment (evaluate 
whether the tremor frequency changes when the patient performs 
a contralateral finger tapping task), distractibility (cessation of 
tremor on distraction by a mental or contralateral movement 
task) and temporary arrest of tremor during a ballistic pointing 
test of the other hand (‘pointing test’). Inability to perform a 
simple cognitive task can also be a sign of a functional movement 
disorder, as well as a sudden onset of the tremor.8 Sometimes 
marked fluctuations of the frequency of a functional tremor 
(between different contexts or spontaneously) can be noticed by 
visual inspection alone, otherwise polymyography can be used 
(step 3). Finally, the examiner may influence the co- contraction 
pattern by moving the patient’s hand passively and note whether 
or not the tremor fluctuates in parallel to the muscle tone.9 This 
can be done during clinical assessment or during polymyography 
(allowing a quantification of muscle contraction and tremor 
amplitude). An important pitfall is that functional movement 
disorders may occur in patients who also have an organic move-
ment disorder.
Second, we suggest looking for so- called ‘prominent additional 
signs’. This distinction is important, because tremor can occur 
in isolation (isolated tremor syndromes) or together with other 
neurological signs (combined tremor syndromes). A distinction is 
made between ‘prominent additional signs’ and so- called ‘signs 
of uncertain significance’.2 The first are clear neurological signs, 
used to define a combined tremor syndrome, such as bradyki-
nesia, cerebellar signs, dystonic posturing, signs of peripheral 
neuropathy and brainstem signs. Examples of ‘signs of uncertain 
significance’ include a mildly unsteady tandem gait, questionably 
abnormal posturing of a body part, mild cognitive impairment, 
questionable bradykinesia or rigidity and other mild neurological 
signs that do not suffice to make an additional syndrome classifi-
cation.2 As can be seen in the algorithm, the weight placed by the 
clinician on an additional symptom (such as dystonic posturing 
of a limb) determines whether a tremor is called dystonic tremor 
or ET ‘plus’. This can be difficult, as outlined under ‘Isolated 
tremor syndromes’ section.
 Combined tremor syndromes
In the right column of the algorithm, the combined tremor 
syndromes are depicted. In classifying a combined tremor 
syndrome, there are five prominent additional signs to look for.
Bradykinesia points to a parkinsonism- associated tremor 
syndrome, such as Parkinson’s disease (PD) or atypical parkin-
sonism (progressive supranuclear palsy (PSP), multiple system 
atrophy (MSA), vascular parkinsonism, dementia with Lewy 
bodies, corticobasal degeneration or medication- induced parkin-
sonism). Tremor in PD (Parkinson’s tremor) is often distal, asym-
metric, it occurs predominantly at rest and has a frequency of 
4–7 Hz. The tremor can show a ‘pill- rolling’ aspect (eg, more 
flexion than extension of the thumb), often spontaneously waxes 
and wanes in amplitude and can improve on levodopa—although 
not necessarily.10 Parkinson’s tremor typically increases in ampli-
tude during cognitive co- activation (eg, serial sevens) or motor 
co- activation with another limb (eg, tapping with the contralat-
eral hand, or walking).11 It classically occurs at rest, but a lot 
of patients also have postural tremor (46%–93%). In 81% of 
these patients, a transient (>1–2 s) suppression of tremor ampli-
tude is seen during a voluntary movement with the trembling 
arm, after which the tremor comes back (re- emergent tremor).12 
Although resting tremor is a key feature of a Parkinson’s tremor, 
19% of the patients show an additional pure postural tremor 
that is independent from the resting tremor (unlike re- emergent 
tremor, which is a continuation of resting tremor during stable 
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Figure 2 Practical clinical algorithm. isolated tremor syndromes are depicted in blue on the left side of the diagram, combined tremor syndromes in 
orange on the right side. Functional tremor is depicted in green on the right side. *For example, mildly unsteady tandem gait, questionably abnormal 
posturing of a body part, mild cognitive impairment, questionable bradykinesia or rigidity and other mild neurological signs of unknown significance that do 
not suffice to make an additional syndrome classification or diagnosis. †For example, anxiety, fatigue, thyrotoxicosis, hypoglycaemia, pheochromocytoma, 
tremor- provoking medication (see table 1).
than in PD, but it can nevertheless be a presenting sign. In 
comparison, tremor in MSA is often jerkier and lacks the clas-
sical ‘pill- rolling’ aspect of rest tremor in PD (12% in MSA vs 
74% in PD), while postural, action and intention tremor are 
more frequently seen in MSA.13 Tremor in PSP is also more often 
present during actions than during rest and it is usually symmet-
rical as opposed to asymmetrical tremor PD, although a PD- like 
tremor has also been reported.14
Cerebellar signs are seen in intention tremor syndromes. 
The main cerebellar sign is ataxia, which can become visible 
as dysmetria of the limbs or eye movements, dysarthria, dysdi-
adochokinesia and unsteady broad- based gait. Clinically, the 
tremor syndrome consists of a unilateral or focal, kinetic and 
slow (<5 Hz) (intention) tremor, which can be accompanied by 
brainstem signs (eg, diplopia, cranial nerve palsy). If there are no 
cerebellar or brainstem signs, but only an intention tremor, the 
diagnosis of isolated intention tremor can be made, though this 
is very rare.2
Dystonic posturing is the key feature of a dystonic tremor 
syndrome. It is now recognised that tremor is a very common 
feature of dystonia, occurring in 17%–55% of patients with 
adult- onset primary dystonia.15 16 A distinction can be made 
between ‘dystonic tremor’, in which dystonia in the affected limb 
is found (eg, head tremor in a patient with cervical dystonia), or 
‘tremor associated with dystonia’, in which dystonia is found in 
any other body part than the tremulous limb (eg, hand tremor in 
a patient with cervical dystonia).2 Dystonic tremors are mostly 
postural or kinetic, but they may also occur at rest. The tremor 
usually has a jerky or irregular aspect, and it can exacerbate by 
attempting to maintain a certain posture.16 17 Sometimes a geste 
antagoniste (sensory trick) can be found, which helps in differ-
entiating dystonic head tremor from essential head tremor,18 as 
does a rest tremor of the head, which seems more common in 
dystonic head tremor. Usually, no improvement on levodopa is 
seen.
Peripheral neuropathy, consisting of distal lower motor 
neuron signs (muscle weakness and atrophy, absent reflexes) and 
distal sensory signs, suggests a neuropathic tremor. This tremor 
is mainly postural, but can also be found at rest, and is most 
frequently found in inflammatory neuropathies like IgM para-
proteinemic neuropathies, chronic inflammatory demyelinating 
neuropathy and multifocal motor neuropathy.19 In very rare 
cases, tremor is associated with a peripheral radiculopathy20 or 
with certain myopathies.21
Brainstem signs are relevant as they can be found in patients 
with myorhythmia. This is a very rare movement disorder 
characterised by rhythmic movements of the cranial or limb 
muscles are seen in rest or during action. It is unilateral or 
focal, of slow frequency (<4 Hz) and often has a jerky aspect. 
Because of its irregular clinical features, it does not conform 
to the traditional definitions of tremor. Therefore, some 
have argued to consider myorhythmia as a separate entity.22 
Oculo- masticatory myorhythmia is nearly pathognomonic 
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box 1 Examination of a patient with tremor
General guidelines:
 ► View straight from in front, such that both arms can be seen 
simultaneously.
 ► Assess tremor for >5 s per condition, ideally 30 s per position.
Activation conditions:
 ► Rest. This is ideally done when the subject lies completely 
relaxed on a bed, especially for (rest) tremor of the head and 
tremor of the lower limbs. If not possible, use an armchair 
(hands dangling down from the armrests, forearm supported) 
or ask the patient to have both forearms pronated in a 
relaxed position.
 ► Rest with cognitive co- activation. Ask the patient to perform 
serial sevens, name as many animals as possible or spell 
a difficult word. Note increased tremor amplitude (eg, in 
Parkinson’s tremor) or reduced tremor amplitude (eg, in 
functional tremor).
 ► Rest with motor co- activation. Ask the patient to make 
tapping movements with the contralateral hand. Look for 
resting tremor in the arms during walking. Note increased 
tremor amplitude (eg, in Parkinson’s tremor) or reduced 
tremor amplitude (eg, in functional tremor).
 ► Change from rest to posture (to identify re- emergent tremor). 
Ask the patient to rapidly extend the wrist and note whether 
this leads to tremor reset (a transient (>1–2 s) suppression 
of the tremor amplitude). This is often seen in Parkinson’s 
tremor.
 ► Postural tremor. Look for tremor when the arms are extended 
towards you (palms down), when the hands are supinated 
and when the hands are pronated. Note position dependence 
(eg, in dystonic tremor). Ask the patient to spread the fingers, 
and note myoclonic movements of individual fingers (eg, in 
polyminimyoclonus). Look for tremor during the wing- beating 
position (both hands before the mouth, not touching each 
other). Note involvement of proximal shoulder muscles in the 
tremor during this position (eg, in dystonic tremor or Holmes 
tremor). Ask and test for position- dependent tremors, for 
example, when a cupis held in a particular position. Test for 
stimulus- sensitivity of the hyperkinetic movement by briefly 
tapping the fingers at the palmar side during posturing (if the 
movements increase, this may indicate cortical myoclonus).
 ► Kinetic tremor. Ask the patient to make slow finger- to- nose 
movements. Distinguish between simple kinetic tremor 
(tremor amplitude remains constant during the entire 
movement) and intention tremor (crescendo increase in 
tremor when affected body part approaches its visual 
target). Ask and test for task- specific kinetic tremor (eg, 
during writing). Ask patients to draw a spiral with each hand 
separately, unsupported by the table.
 ► Note tremor in other locations than the arms. For example, 
the head, face, tongue, voice, legs, trunk.
signs of functional tremor
 ► Note abrupt changes in tremor movement. For example, 
changing from wrist flexion/extension to pronation/
supination, from left to right or between body parts.
 ► Note distractibility. Look for disappearance of tremor during 
cognitive or motor co- activation. Also note inability of the 
patient to perform simple tasks.
 ► Note entrainment. Ask the patient to make tapping 
movements with the contralateral hand at different 
frequencies, and note whether the tremor rhythm adopts 
Continued
box 1 Continued
these frequencies. Distinguish entrainment from mirror 
movements (which occur in many movement disorders).
 ► Perform pointing test. Ask the patient to keep the tremulous 
limb in the position where the tremor occurs (eg, stretched 
out), move it slightly out of view of the patient and focus 
on the contralateral arm. Ask the patient to make a rapid, 
ballistic movement with that arm (eg, grab the examiner’s 
finger). The pointing test if positive if the tremor is briefly 
suppressed during the movement of the contralateral arm.
by a slow convergent- divergent nystagmus and a vertical 
ophthalmoparesis.23
Finally, patients may present with multiple additional signs. 
For example, 30%–60% of patients with PD also have dystonic 
posturing.24 In Holmes tremor, many patients have additional 
signs of ataxia and/or dystonia. Holmes tremor is a slow 
(<5 Hz), unilateral, more proximal tremor, which is seen during 
actions and at rest. The tremor usually has a high amplitude, 
is irregular in appearance and often involves proximal muscles. 
Furthermore, it can be accompanied by brainstem or thalamic 
signs (eg, lateralised sensory disturbances), because a lesion is 
usually found in these locations.25
 Isolated tremor syndromes
In the left column of the algorithm, the isolated tremor 
syndromes are depicted.
The most likely diagnosis in a patient presenting with a 
bilateral upper limb action tremor is ET, as it has the highest 
prevalence, and the prevalence and severity increases with age. 
Bilateral action tremor is mandatory for this diagnosis. Formally, 
this tremor syndrome has at least 3 years of duration, (otherwise 
it ought to be called an isolated action tremor), without a sudden 
onset, stepwise deterioration or task or position specificity. The 
tremor can spread to other locations (eg, head, voice or lower 
limbs). It improves with the use of alcohol in 50% of the cases, 
although it should be noted that alcohol can also reduce other 
tremors due to its sedative effects. Furthermore, self- reported 
alcohol responsiveness correlates poorly with actual objectified 
responsiveness,26 so a history of alcohol sensitivity has limited 
value as a diagnostic tool. Half of the ET patients report a positive 
family history.27 Of the patients diagnosed with an ET syndrome 
at a tertiary referral centre, 42% had an intention tremor.28 In 
severe cases, a rest tremor can also be found (around 18%).29 
In advanced disease, tandem gait abnormalities can be found.30
If there are additional signs ‘of uncertain significance’ in a 
patient who otherwise fulfils the criteria for ET, then the recent 
consensus classifies this as ET plus. This could be impaired 
tandem gait, questionable dystonic posturing, memory impair-
ment or other mild neurological signs. Likewise, ET with tremor 
at rest should be classified here.2 Over the last few years, there 
has been considerable discussion over the term ‘ET plus’. A 
recent study showed that, in ET patients with lower limb tremor, 
110/133 (83%) were re- classified as ET plus, and these patients 
were older than the ET group.31 This shows that many patients 
with ET have additional symptoms, which may be integral to 
the disease, reflect comorbidity or it may be related to ageing. 
Another issue is that it is not easy to determine the clinical 
significance of additional symptoms. Specifically, two recent 
studies have shown that there is only fair agreement between 
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modest inter- rater agreement between axis 1 diagnoses (espe-
cially between ET plus and dystonic tremor).33 Neurophysio-
logical measures, such as temporal discrimination thresholds, 
also cannot provide clear distinctions between ET and dystonic 
tremor, although this may be useful when classifying indetermi-
nate tremors.34 These findings show that the borders between 
some clinical tremor syndromes are not fixed, which may indi-
cate a shared pathophysiological basis.3 Accordingly, it has been 
argued that ‘ET plus’ may represent a state condition, such that 
additional signs emerge during certain stages of ET,35 or a tempo-
rary label, such that patients with ET plus transition to a more 
definite diagnosis.36 In the future, incorporation of pathophysi-
ological information (a potential ‘third axis’) may help to better 
classify tremor syndromes, but this requires better biomarkers 
than are currently available. Until then, we recommend to not 
rest at a diagnosis of ‘ET plus’, and to explicitly note and follow 
the relevant ‘plus symptom’. The general principle that axis 1 
classifications may change over time is, however, not specific to 
ET plus.
A second consideration is whether the clinical phenotype fits 
the diagnosis of enhanced physiological tremor (EPT). The limbs 
and head, when unsupported, exhibit slight tremor in every 
living person,37 and it is this physiological tremor that is exac-
erbated in EPT. When taking the patient’s history, search for an 
influence of provoking factors such as anxiety, fatigue, thyrotox-
icosis, hypoglycaemia, pheochromocytoma or tremor inducing 
medication. The typical phenotype consists of a bilateral, distal, 
mostly postural tremor, which is a little faster than ET, and has 
a lower amplitude than ET.38 The diagnosis is confirmed by 
normalisation of the tremor after management of the provoking 
condition.2
The last group of isolated tremors consists of other isolated 
tremor syndromes. These syndromes might develop over time 
into a combined tremor syndrome, for example, primary writing 
tremor may evolve to dystonic tremor syndrome, or an isolated 
rest tremor may be precursor of PD. We distinguish four other 
isolated tremor syndromes2:
1. Isolated rest tremor: rest tremor without other clinical fea-
tures (such as bradykinesia or dystonia) most commonly oc-
curs in an upper or lower limb or as a hemitremor, but it 
may occur elsewhere (eg, lips, jaw or tongue). If an isolated 
rest tremor has the clinical features of a Parkinson trem-
or (figure 2), nuclear imaging may be considered if there is 
doubt about the presence or absence of bradykinesia (step 
7).
2. Isolated intention tremor: intention tremor <5 Hz without 
localising signs, which is very rare.
3. Isolated focal tremors (voice, head, jaw, face, others), for ex-
ample, isolated voice tremor: visible and/or audible tremor 
of the vocal apparatus (not in the context of dystonia) or 
isolated head tremor: shaking of the head like yes- yes or no- 
no, or variable directions, etc.
4. Isolated task- specific and position- specific tremors (writing, 
sports, musicians): occur during a specific task or posture 
(eg, primary writing tremor or yips in golfers).
step 3: is polymyography indicated?
Polymyography can be used to support the suspected clinical 
diagnosis or advance the clinical characterisation of the tremor. 
However, the value depends on the skills and experience of the 
neurophysiologist. Therefore, the availability of polymyography 
varies between centres and the quality is highest in specialised 
clinics. This can be a reason for referral of particularly difficult 
cases. There are a number of specific situations in which it can 
be of help.
First, polymyography can be used to make the distinction 
between tremor and myoclonus. Look for characteristics of 
(cortical) myoclonus such as 1) short electromyogram (EMG) 
bursts (<50–100 ms), 2) at an irregular frequency, 3) in a 
synchronous agonist- antagonist contraction pattern, 4) or tran-
sient loss of muscle tone (negative myoclonus). More advanced 
techniques, such as back- averaging and coherence analysis, 
include a combination of EMG and electroencephalogram 
(EEG) in search for signs of cortical drive.39–41 It should be borne 
in mind that epilepsia partialis continua is not always associated 
with epileptic EEG activity: in ±17% of cases, the ictal EEG is 
normal.42
A second useful application is the objective assessment of 
signs associated with functional tremor, such as entrainment 
and distractibility (step 2). Functional tremor can present as an 
alternating tremor or as a co- contraction tremor. A co- contrac-
tion tremor (where agonist and antagonist muscles increase limb 
stiffness, resulting in a fine, high- frequency tremor) can be more 
resistant to entrainment and distraction. In these cases, poly-
myography can be used to identify the co- contraction pattern, 
which is typically present at the onset of posturing. Furthermore, 
the pointing test is often positive in co- contraction tremor, and 
polymyography is more sensitive to detect this than the clinical 
eye. In 2016, a test battery was validated as laboratory- supported 
criteria for the diagnosis of functional tremor, including an 
increase of tremor amplitude on loading, tonic discharge of 
antagonist muscles approximately 300 ms before tremor onset, 
entrainment or increase in variability and change of tremor 
frequency while tapping with the contralateral hand, less accu-
rate tapping performance at requested frequencies, significant 
interlimb coherence in bilateral tremors and transient arrest of 
tremor during ballistic movements of the other hand.43 By appli-
cation of this test battery at a cut- off score of ≥3/10 points, func-
tional tremor can be distinguished from organic tremor with a 
sensitivity of 90% and a specificity of 96%. While many of these 
tests can be done clinically, polymyography is usually more sensi-
tive and in some cases necessary, for example, for calculating 
coherence. Moreover, spontaneous and marked (>1 Hz) vari-
ability in tremor frequency throughout the registration is also 
a marker of functional tremor.28 44 It is important to appreciate 
that while most tests for functional tremor have a high specificity, 
none are 100% specific. In other words, ‘functional’ characteris-
tics can occasionally occur in otherwise ‘organic’ tremor, and it 
is of course possible that an existing organic tremor is aggravated 
by functional tremor. Complimentary to the establishment of 
functional characteristics, polymyography can be an important 
identifier of tremor with an unusual clinical appearance. These 
unusual tremors are sometimes incorrectly recognised as func-
tional tremor, as can happen in lesion- based tremors such as 
Holmes tremor or myorhythmia.45
A third use of polymyography is to differentiate between EPT 
and ET. EPT has mechanical and mechanical- reflex components 
but only rarely central components (±10%), while ET has a 
central origin. Mechanical components are body part oscillations 
that are driven by factors such as cardiac systole, breathing and 
irregularities in muscle contraction. These mechanical compo-
nents may trigger a reflex response in the muscle under certain 
circumstances (eg, fatigue, stress, intake of adrenergic medica-
tion). The resulting tremor can be influenced by mechanical 
factors such as inertial loading or by changing the movement tasks 
or postures. This introduces changes in stiffness or the contribu-
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Table 1 Overview of medication and toxins that may cause 
tremor52 53
Medication Toxins
Sympathomimetic drugs (adrenaline 
epinephrine, bronchodilators, theophylline)
Drugs of abuse (nicotine, alcohol and 
its withdrawal, cocaine, caffeine)
Antiarrhythmics (amiodarone) Lead
Metoclopramide Mercury
Antidepressants (SSRI, TCA) Manganese
Lithium Arsenic
Neuroleptics, tetrabenazine Cyanide, DDT, CO
Antiepileptic drugs (valproic acid, 
carbamazepine, phenytoin)
Naphthalene
Immunosuppressants (tacrolimus, ciclosporin) Toluene
Anticancer drugs (vincristine, cisplatin, 
paclitaxel, doxorubicin, cytosine arabinoside, 




Steroids (progesterone, anti- estrogens, 
adrenocorticosteroids)
Pesticides
CO, carbon monoxide; DDT, dichlorodiphenyltrichloroethane; SSRI, selective 
serotonin reuptake inhibitor; TCA, tetracyclic antidepressants.
a change in these factors leads to a change in tremor frequency, 
this points towards EPT.46 A decrease in tremor frequency after 
inertial loading is a specific finding47 48 (see Longardner et al for 
an instructional video on how to conduct this test properly).49 A 
higher frequency (>8 Hz) also points towards EPT.
Finally, polymyography may be helpful when selecting appro-
priate muscles for botulinum toxin treatment in patients with 
(dystonic) tremor. Polymyography can also confirm the low 
frequency (<5 Hz) that is typical of Holmes tremor, as frequency 
is difficult to judge by eye.50 51
step 4: is the tremor medication or toxin induced?
After clinical phenotyping as described in steps 1–3, the next 
steps provide a systematic way to search for an aetiology. Use of 
tremorgenic medication is a common cause of mainly enhanced 
physiological and parkinsonism- associated tremor: the tremor 
emerges after the start or dose escalation of the offending drug 
and vanishes usually shortly after discontinuation.52 An over-
view of medicines and toxins that are known to cause tremor 
is provided in table 1.53 A tremor produced by lithium, anti-
depressants or toxins frequently has the clinical appearance of 
rhythmic cortical myoclonus. Exposure to toxins is common in 
certain occupations and tremor can be the first manifestation 
in a constellation of exposure toxicity signs and symptoms. It is 
important to recognise these acquired causes of tremor, because 
reduction or removal of the medication or toxic agent is the first 
step in treating these patients.
step 5: are laboratory tests indicated aimed at an acquired 
cause or treatable metabolic disorder?
Tremor and myoclonus can be caused by forms of organ failure 
or homeostatic imbalance, such as renal failure, hepatic failure, 
hyperthyroidism and disturbed glucose metabolism. These 
causes are important to identify, as treatment leads to cessation 
of tremor. Basic laboratory testing is therefore advised, espe-
cially in patients with a bilateral isolated tremor syndrome, and 
this should include thyroid, liver and renal function, glucose and 
electrolytes. The exact yield of these tests is, however, unknown. 
Other tests should only be performed when they are specifically 
indicated, to minimise unsolicited findings. In isolated tremor, 
investigate serum catecholamines if there are other symptoms 
of pheochromocytoma (ie, episodes of headache, sweating 
and/or tachycardia).54 Test for toxins when there is a history 
of exposure.53 In tremor combined with dystonia or a family 
history of movement disorders and cognitive or psychiatric 
symptoms, consider testing copper and iron metabolism (serum 
copper, ceruloplasmin, iron, ferritin) as this can point to Wilson 
disease55 or neurodegeneration with brain iron accumulation56 
(particularly neuroferritinopathy). Apart from Wilson disease, 
there are other treatable metabolic diseases that typically present 
with dystonia or ataxia but in which patients are occasionally 
reported to have tremor. These include Niemann- Pick type C, 
glutaric aciduria type 1, ataxia with vitamin E deficiency, Segawa 
disease and coenzyme Q10 deficiency (table 1).57–59 In case of 
a tremor associated with neuropathy, test for acquired causes, 
including paraproteinemia.
step 6: is an MrI indicated?
A cerebral MRI scan is worthwhile when the differential diag-
nosis includes an aetiology resulting in structural abnormalities. 
As a guiding principle, we propose to perform an MRI in patients 
with a combined tremor syndrome that is 1) focal/unilateral, 2) 
non- classical in appearance, 3) in case there is a sudden onset 
or stepwise deterioration or 4) a family history of movement 
disorders combined with cognitive or psychiatric symptoms. 
The latter suggests a heritable neurodegenerative or metabolic 
disorder, which can sometimes be identified using MRI. Look 
for lesions or atrophy in the basal ganglia, cerebellum and brain-
stem. Based on the clinical characteristics identified in step 2, 
specific signs to look for include hummingbird sign, morning 
glory sign and hot cross bun sign in atypical parkinsonism60 
(combined with bradykinesia); panda sign in Wilson disease61 
(combined with dystonia) and middle cerebral peduncle and 
splenium sign in fragile X- associated tremor ataxia syndrome 
(FXTAS, combined with ataxia).22 62 Generally, patients with an 
isolated tremor syndrome will have normal MRI scans and thus 
structural imaging is not indicated. However, this rule of thumb 
should be abandoned in isolated patients with tremor in case of 
either hints at an acquired cause (sudden onset or stepwise dete-
rioration, unilateral tremor), or a family history of movement 
disorders combined with cognitive or psychiatric symptoms. A 
brain MRI is unnecessary to diagnose a functional tremor, but 
we recognise that it is sometimes needed to reassure a patient 
who has remaining fears about an alternative diagnosis despite 
the neurologist’s explanation.63
step 7: is presynaptic dopamine transporter imaging 
indicated?
Presynaptic dopamine transporter imaging (123I- FP- CIT SPECT 
(DaT- SPECT)) can be helpful in some patients with tremor. Dopa-
mine receptor imaging (such as F- DOPA PET) can also be used, 
but this is much less common in most clinics. Here, we propose 
guiding principles on indications for nuclear imaging: these 
are not extensively evidence- based due to a lack of good data 
and the absence of gold standard for many tremor syndromes. 
Because this technique is aimed at assessing the presence of a 
presynaptic dopaminergic deficit, it will only be relevant if 
we wish to differentiate tremor related to parkinsonism from 
other tremor syndromes, and considerable doubt remains after 
steps 1–6 have been taken. More specifically, presynaptic dopa-
mine transporter imaging is well suited to distinguish between 
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Table 2 Treatable metabolic disorders that may evoke tremor57–59
Metabolic disorder Movement disorders Laboratory tests Gene
Wilson disease Dystonia, parkinsonism, ataxia, chorea, 
tremor
Serum ceruloplasmin, 24 hours urinary copper excretion ATP7B
niemann- Pick type C Ataxia, dystonia, rarely tremor Oxysterols, chitotriosidase NPC1, NPC2
Glutaric aciduria type 1 Dystonia, parkinsonism, chorea, rarely 
tremor
Plasma+urine organic acids, plasma acylcarnitines GCDH
Ataxia with vitamin E deficiency Ataxia, dystonia, rarely tremor Plasma vitamin E level TTPA
segawa disease (drd) Dystonia, parkinsonism, tremor CSF dopamine levels GCH1
Coenzyme Q10 deficiency Ataxia, dystonia, tremor, spasticity Serum lactate, biochemical activities of respiratory chain 
complexes in skin or muscle, muscle CoQ10 level
Multiple genes
CSF, cerebrospinal fluid; DRD, dopa- responsive dystonia.
which can be a cause of scans without evidence of dopaminergic 
deficit in suspected patients with PD.65 However, although 
presynaptic dopamine transporter imaging is used to distinguish 
drug- induced parkinsonism from neurodegenerative forms of 
parkinsonism,66 it cannot reliably make a distinction between 
the different causes of a parkinsonism- associated tremor.67
step 8: are genetic tests indicated?
Genetic testing can be considered but should be limited to 
particular situations. There are several genetic mutations that 
can cause a clinical syndrome that includes tremor. However, 
in a patient presenting with isolated tremor, there is currently 
no indication for genetic testing as no disease- causing genes 
are known for isolated tremor syndromes. This underlines the 
importance of clinical examination and particularly the differ-
entiation in isolated versus combined tremor syndromes, as 
depicted in figure 2.
Genetic testing can be considered in patients with a combined 
tremor and a family history of movement disorders, cognitive 
symptoms, psychiatric symptoms or neuropathy. For instance, 
a familial syndrome consisting of tremor and ataxia could 
point towards FXTAS68 or a spinocerebellar atrophy (SCA).69 
In Klinefelter syndrome, a predominantly postural and kinetic 
tremor has been described, sometimes with dystonic features.70 
More rarely, a combination of tremor and ataxia can be found 
in patients with adult ataxia telangiectasia71 or inborn errors of 
metabolism such as Niemann- Pick type C72 (figure 2). Tremor 
can also be a feature in the clinical presentation of some of the 
early onset/familial parkinsonisms.73 In familial cases of tremor 
and dystonia, DYT3 (Lubag’s disease)74 and DYT24 (ANO3)75 
can be considered, as well as metabolic disorders (table 2). 
Particularly consider Wilson disease55 and Niemann- Pick type 
C if the movement disorders coincide with cognitive or psychi-
atric symptoms. Moreover, in patients with familial neuropathy 
and tremor, several Charcot- Marie- Tooth variants are possible,19 
as well as spinal bulbar muscle atrophy (Kennedy’s disease).76 
Overall, these examples illustrate that genetic testing is only 
feasible in patients with a combined tremor syndrome and a 
relevant family history.
In some instances, a particular genetic diagnosis will be suspected 
and tested by means of conventional Sanger sequencing, but if 
the list of possible genes is long next- generation sequencing will 
be the method of choice. This can be done either by using whole- 
genome sequencing (WGS), whole exome sequencing (WES) or 
targeted resequencing (TRS) panels that focus on a selection 
of known disease- causing genes. An advantage of diagnostic 
gene panels over WGS and WES is that it evades the dilemmas 
connected to the discovery of unsolicited findings. However, 
a targeted gene panel needs to be continuously updated with 
regard to newly established disease genes to be equally effec-
tive as WGS or WES, and a tremor gene panel may not be in 
place. Moreover, be aware that next- generation sequencing 
is not sensitive for repeat expansions (such as FXTAS, SCAs) 
and mitochondrial DNA mutations (such as sensory ataxia with 
neuropathy, dysarthria and ophthalmoparesis). Currently, the 
cost of next- generation sequencing techniques is falling rapidly 
and comparable to that of sequencing three individual genes. 
For further guidance, we advise soliciting a clinical geneticist for 
patients in whom genetic testing is indicated.
ConCLusIons
We have proposed a stepwise diagnostic approach to patients 
presenting with upper limb tremor, to guide clinicians in estab-
lishing a clinical tremor syndrome and performing the rele-
vant tests to determine its aetiology. The proposed diagnostic 
algorithm is in line with the latest Consensus Statement2 and 
encourages clinicians to make a distinction between isolated and 
combined tremor syndromes, based on clinical features. This 
is key, as this distinction subsequently informs our choices for 
diagnostic testing. We believe that our diagnostic algorithm will 
be useful to practising neurologists whether they have expertise 
in the field of movement disorders or not. The stepwise setup 
tapers diagnostic tests, starting with those tests that are easily 
available and indicated in most patients, and finishing with more 
specialised diagnostic procedures, including considerations for 
next- generation genetic testing. By following the presented 
steps, the long list of possible causes for tremor is reduced to 
manageable portions. We hope that the approach proposed in 
this article will decrease diagnostic uncertainty and increase the 
diagnostic yield in patients with tremor.
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